50 related articles for article (PubMed ID: 23153762)
1. Synergistic antivirus effect of combined administration of Combivir with Angelica polysaccharide sulfate.
Yang T; Jia M; Yue Z; Cheng Y; Zhang X; Huang J; Zhou S; Mei Q
Int J Biol Macromol; 2013 Feb; 53():122-6. PubMed ID: 23153762
[TBL] [Abstract][Full Text] [Related]
2. Antivirus and immune enhancement activities of sulfated polysaccharide from Angelica sinensis.
Yang T; Jia M; Zhou S; Pan F; Mei Q
Int J Biol Macromol; 2012 Apr; 50(3):768-72. PubMed ID: 22155400
[TBL] [Abstract][Full Text] [Related]
3. Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.
Rozenbaum W; Katlama C; Massip P; Bentata M; Zucman D; Delfraissy JF; Trepo C; David F; Lanier ER; Vavro C; Mamet JP
Antivir Ther; 2001 Jun; 6(2):135-42. PubMed ID: 11491418
[TBL] [Abstract][Full Text] [Related]
4. Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro.
Piras G; Makino M; Baba M
Microbiol Immunol; 1997; 41(10):835-9. PubMed ID: 9403512
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir containing regimen.
Matsushita S; Yoshimura K; Kimura T; Kamihira A; Takano M; Eto K; Shirasaka T; Mitsuya H; Oka S
J Clin Virol; 2005 Jul; 33(3):188-93. PubMed ID: 15911439
[TBL] [Abstract][Full Text] [Related]
6. Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity.
Freund YR; Dabbs J; Creek MR; Phillips SJ; Tyson CA; MacGregor JT
Toxicol Appl Pharmacol; 2002 May; 181(1):16-26. PubMed ID: 12030838
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Uckun FM; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
[TBL] [Abstract][Full Text] [Related]
8. Mixed results.
Posit Aware; 2000; 11(1):25. PubMed ID: 11366343
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
10. What you need to know about Combivir.
AIDS Alert; 1998 Jan; 13(1):suppl 1. PubMed ID: 11364867
[TBL] [Abstract][Full Text] [Related]
11. Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
Matheron S; Descamps D; Boué F; Livrozet JM; Lafeuillade A; Aquilina C; Troisvallets D; Goetschel A; Brun-Vezinet F; Mamet JP; Thiaux C;
Antivir Ther; 2003 Apr; 8(2):163-71. PubMed ID: 12741629
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus.
McKallip RJ; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 1995 Mar; 131(1):53-62. PubMed ID: 7878678
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of fraction 1a of polysaccharides isolated from Solanum nigrum Linne on thymus in tumor-bearing mice.
Li J; Li Q; Peng Y; Zhao R; Han Z; Gao D
J Ethnopharmacol; 2010 Jun; 129(3):350-6. PubMed ID: 20371278
[TBL] [Abstract][Full Text] [Related]
14. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combined administration of Angelica polysaccharide and cytarabine on liver of human leukemia NOD/SCID mouse model].
Zhu JH; Xu CY; Mu XY; Liu J; Zhang MS; Jia DY; Zhang YY; Huang GN; Wang YP
Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):121-5. PubMed ID: 24754180
[TBL] [Abstract][Full Text] [Related]
17. A polysaccharide from Strongylocentrotus nudus eggs protects against myelosuppression and immunosuppression in cyclophosphamide-treated mice.
Wang H; Wang M; Chen J; Tang Y; Dou J; Yu J; Xi T; Zhou C
Int Immunopharmacol; 2011 Nov; 11(11):1946-53. PubMed ID: 21723424
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
[TBL] [Abstract][Full Text] [Related]
19. Alteration of thymic cell subsets by cocaine administration and murine retrovirus infection in protein undernourished mice.
Lopez MC; Colombo LL; Huang DS; Watson RR
Thymus; 1992 Nov; 20(3):171-81. PubMed ID: 1334287
[TBL] [Abstract][Full Text] [Related]
20. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
